Randomized, Controlled Trial of High-Dose Influenza Vaccine Among Frail Residents of Long-Term Care Facilities

Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults

(2014) Carlos A. DiazGranados et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cochrane re-arranged: Support for policies to vaccinate elderly people against influenza

(2013) Walter E.P. Beyer et al.   VACCINE

Postlicensure Safety Surveillance for High-Dose Trivalent Inactivated Influenza Vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010

(2012) P. L. Moro et al.   CLINICAL INFECTIOUS DISEASES

High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: Safety, immunogenicity and relative efficacy during the 2009–2010 season

(2012) Carlos A. DiazGranados et al.   VACCINE

Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59®adjuvant

(2012) Giovanni Della Cioppa et al.   Human Vaccines & Immunotherapeutics

Lessons learned from an osteoporosis clinical trial in frail long-term care residents

(2011) SL Greenspan et al.   Clinical Trials

Inactivated Influenza Vaccines

(2011) Valentina Parodi et al.   DRUGS & AGING

Gait Speed and Survival in Older Adults

(2011) Stephanie Studenski   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Influenza Hemagglutination-Inhibition Antibody Titer as a Correlate of Vaccine-Induced Protection

(2011) Suzanne E. Ohmit et al.   JOURNAL OF INFECTIOUS DISEASES

Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine

(2011) Wilbur H. Chen et al.   VACCINE

Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine

(2010) Seth J Sullivan et al.   Expert Review of Vaccines

Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force

(2010) Gabor Abellan Van Kan et al.   Journal of Nutrition Health & Aging

Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence

(2010) Joon Young Song et al.   VACCINE

Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and Older

(2009) Ann R. Falsey et al.   JOURNAL OF INFECTIOUS DISEASES

A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects

(2009) Thomas R. Cate et al.   VACCINE

Rapid Decline of Influenza Vaccine–Induced Antibody in the Elderly: Is It Real, or Is It Relevant?

(2008) Danuta M. Skowronski et al.   JOURNAL OF INFECTIOUS DISEASES